Archive for 2016

Dartmouth Institute Research Roundup 5.16

Dartmouth Institute Research Roundup 5.16

Learn about recent Dartmouth Institute research on ER visits for “non-urgent” conditions, physician knowledge of the FDA-approval process, the possible overuse of CT scans in the ER, patient recording of clinical encounters, and a more patient-centered approach to statistical modeling.

Is Contrave Worth Trying If You Want to Lose Weight? – Consumer Reports

Read article – Quotes Lisa Schwartz, professor of medicine, community and family medicine, and of the Dartmouth Institute for Health Policy and Clinical Practice (TDI), about how she and colleague Steven Woloshin, professor of medicine, community and family medicine, and of TDI, reviewed the studies that weight loss drug Contrave’s manufacturer, Orexigen Therapetutics, used to gain approval of the drug from the Food and Drug Administration. “The studies show that Contrave caused many people to feel sick,” says Schwartz.

Valley Parents: Group Bridges Gap for LGBT Teens – Valley News

Read article – Feature article about Ana Rodriguez-Villa, a second year Geisel student, and Brendin Beaulieu-Jones, ’13, also a second-year med student at Geisel, who co-founded the group Bridges, a peer support group for LGBT teens, last April as part of the Albert Schweitzer Fellowship. As Schweitzer fellows, Rodriguez-Villa and Beaulieu-Jones have developed a curriculum for training first- and second-year medical students to work with LGBT individuals in a clinical setting.